Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Rabies virus phosphoprotein (P), matrix protein (M), and RNA-directed RNA polymerase (L) are essential components of the Rabies virus (RABV) life cycle, collectively facilitating viral replication, transcription, and assembly. The L protein is the catalytic core of the RNA-dependent RNA polymerase (RdRp) complex, performing all enzymatic activities required for RNA synthesis, capping, and polyadenylation (PMID: 28724771). The P protein serves as a vital cofactor for the L protein and a chaperone for the nucleoprotein, while also acting as a major interferon antagonist that suppresses the host immune response (PMID: 16140868). The M protein is a multifunctional structural protein that regulates the balance between viral transcription and replication and mediates the budding of progeny virions from the host cell membrane (PMID: 11832466). Because these proteins are indispensable for viral survival and lack human homologs, they are prime targets for antiviral drug development. Experimental drugs such as Favipiravir target the L protein's polymerase activity to inhibit viral progression (PMID: 24954874). Therapeutic challenges include the rapid progression of the disease and the difficulty of delivering inhibitors across the blood-brain barrier to the infected neurons (PMID: 30634450).
Inhibition of the RNA-dependent RNA polymerase (RdRp) complex, leading to the termination of viral RNA synthesis or the induction of lethal mutations in the viral genome (PMID: 24954874).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rabies virus phosphoprotein (P), matrix protein (M), and RNA-directed RNA polymerase (L) (RABV P-M-L).